Trust & legal

Product safety & responsible deployment

Practical safety considerations for introducing Bedbord or TESS into a care setting.

Updated 15 September 2026 Version 1.0

Intended use and limits

Bedbord is described on this website as a bedside information and communication display. TESS is described as a tablet-based engagement and communication experience. Neither is presented as a replacement for clinical judgement, approved records, staff observation or emergency systems.

A product name or marketing description does not settle medical-device classification. Request the manufacturer’s current intended-use statement and any applicable regulatory assessment for the exact release and hardware.

Bedbord information checks

  • Agree which information can be visible, to whom and in which physical location.
  • Identify who is responsible for updates and verification, including admission, transfers and discharge.
  • Assess the risk of stale, missing or misattributed information and how the system makes it apparent.
  • Verify identity, allergies and clinical decisions through your approved records and procedures.
  • Define a usable fallback for device, network or power failure and train staff in it.

TESS supported use

Choose activities around the person’s preferences and current support needs. AI conversation may be inaccurate; sign-based tools are not a substitute for a qualified interpreter. Do not use entertainment or AI outputs for clinical advice.

Agree supervision, safeguarding, content permissions, volume and shared-account arrangements. Give the person a way to stop, change activity or decline. Confirm handling, charging, connectivity and cleaning instructions before introducing a device.

Local deployment assessment

Include clinical, digital, information-governance, accessibility, infection-prevention and procurement stakeholders as appropriate. Review device placement, mounting, cables, electrical requirements, visibility and cleaning. Do not infer approved disinfectants or electrical suitability from the look of a device.

Where applicable, DCB0129 concerns clinical risk management by health IT manufacturers and DCB0160 concerns deployment and use by health and care organisations. Applicability and evidence must be assessed for the intended use; a marketing page cannot establish conformance.

Reporting and escalation

If an issue could affect immediate care, follow the local clinical escalation route first and use approved alternatives. Report the product issue to your organisation’s responsible lead and support@truselv.co.uk. Include the product, version, device identifier and a description without personal health data.

Product-specific support commitments, incident routes and responsibilities must be recorded in the deployment agreement. This website is not a continuously monitored clinical incident service.

Evidence and references

Use the trust centre and procurement discussion checklist to structure an evidence request.

Reference: NHS service standard: make your service clinically safe. The NHS review of DCB0129 and DCB0160 provides current context on the standards review.

Your privacy

This site uses no advertising cookies, analytics trackers or third-party video embeds. Fonts, images and videos are served with the site.

Forms and the basket stay in this page’s memory and are cleared when you leave or reload. Opening secure checkout loads Stripe’s payment form and necessary payment/fraud-prevention technology. Stripe’s privacy policy applies; see our cookie policy. App stores have their own policies.

Read the cookie policy